Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.

Detalles Bibliográficos
Main Authors: Jadersten, M, Pellagatti, A, Forsblom, A, Emanuelsson, E, Merup, M, Samuelsson, J, Wainscoat, J, Boultwood, J, Hellstorm-Lindberg, E
Formato: Conference item
Publicado: 2005
_version_ 1826285038714486784
author Jadersten, M
Pellagatti, A
Forsblom, A
Emanuelsson, E
Merup, M
Samuelsson, J
Wainscoat, J
Boultwood, J
Hellstorm-Lindberg, E
author_facet Jadersten, M
Pellagatti, A
Forsblom, A
Emanuelsson, E
Merup, M
Samuelsson, J
Wainscoat, J
Boultwood, J
Hellstorm-Lindberg, E
author_sort Jadersten, M
collection OXFORD
description
first_indexed 2024-03-07T01:22:50Z
format Conference item
id oxford-uuid:90f43bae-cf2d-47ac-a193-8c53ded433b9
institution University of Oxford
last_indexed 2024-03-07T01:22:50Z
publishDate 2005
record_format dspace
spelling oxford-uuid:90f43bae-cf2d-47ac-a193-8c53ded433b92022-03-26T23:15:17ZLenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:90f43bae-cf2d-47ac-a193-8c53ded433b9Symplectic Elements at Oxford2005Jadersten, MPellagatti, AForsblom, AEmanuelsson, EMerup, MSamuelsson, JWainscoat, JBoultwood, JHellstorm-Lindberg, E
spellingShingle Jadersten, M
Pellagatti, A
Forsblom, A
Emanuelsson, E
Merup, M
Samuelsson, J
Wainscoat, J
Boultwood, J
Hellstorm-Lindberg, E
Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
title Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
title_full Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
title_fullStr Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
title_full_unstemmed Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
title_short Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
title_sort lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome mds patients with 5q deletion
work_keys_str_mv AT jaderstenm lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT pellagattia lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT forsbloma lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT emanuelssone lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT merupm lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT samuelssonj lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT wainscoatj lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT boultwoodj lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion
AT hellstormlindberge lenalidomideselectivelyinhibitsinvitrogrowthofthemalignantcloneinmyelodysplasticsyndromemdspatientswith5qdeletion